Karyopharm Therapeutics Inc. (KPTI)

USD 5.9

(-5.9%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 240.43 Million 358.17 Million 305.3 Million 313.05 Million 294.96 Million 341.19 Million
Total Current Assets 233.92 Million 326.75 Million 258.09 Million 289.53 Million 273.66 Million 334.61 Million
Cash And Short Term Investments 192.1 Million 277.96 Million 228.61 Million 273.45 Million 263.97 Million 328.19 Million
Cash and Cash Equivalents 52.89 Million 135.18 Million 190.45 Million 85.91 Million 128.85 Million 118.02 Million
Short Term Investments 139.21 Million 142.77 Million 38.15 Million 163.32 Million 133.09 Million 210.17 Million
Net Receivables 26.96 Million 47.08 Million 22.49 Million 12.88 Million 7.86 Million -
Inventory 3.04 Million 4.22 Million 4.1 Million 2.64 Million 346 Thousand -
Other Current Assets 11.81 Million 19.82 Million 2.88 Million 559 Thousand 1.48 Million 6.41 Million
Total Non-Current Assets 6.51 Million 31.42 Million 47.2 Million 23.51 Million 21.29 Million 6.58 Million
Net PPE 4.88 Million 7.37 Million 1.64 Million 2.21 Million 3.04 Million 3.86 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 301 Thousand 633 Thousand 637 Thousand 24.21 Million 2.01 Million 2 Million
Tax Assets - - - - - -
Other Non Current Assets 1.33 Million 23.41 Million 44.92 Million -2.92 Million 16.23 Million 716 Thousand
Other Assets 1.00 - - - - -
Total Liabilities 376.64 Million 374.82 Million 384.97 Million 262.5 Million 245.18 Million 158.02 Million
Total Current Liabilities 69.47 Million 65.9 Million 73.71 Million 297 Thousand 46.35 Million 46.9 Million
Account Payables 3.12 Million 2.77 Million 1.6 Million 4.45 Million 985 Thousand 4.33 Million
Tax Payables - - - - - -
Short Term Debt 3.3 Million 2.87 Million 2.31 Million 1.91 Million 1.64 Million 32.88 Million
Deferred Revenue - - 69.12 Million 297 Thousand 2.34 Million 9.36 Million
Other Current Liabilities 63.04 Million 60.26 Million 678 Thousand -6.36 Million 41.37 Million 327 Thousand
Total Non Current Liabilities 307.16 Million 374.82 Million 384.97 Million 262.2 Million 245.18 Million 111.11 Million
Long-Term Debt 170.91 Million 170.1 Million 169.29 Million 117.92 Million 109.85 Million 102.66 Million
Deferred Revenue Non Current 132.47 Million 132.71 Million 132.99 Million 73.08 Million 4.53 Million 4.53 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 978 Thousand 204.72 Million 215.68 Million 144.27 Million 57.21 Million 97.42 Million
Other Liabilities - -65.9 Million -73.71 Million - -46.35 Million -
Total Equity -136.2 Million -16.65 Million -79.67 Million 50.54 Million 49.77 Million 183.17 Million
Stock Holders Equity -136.2 Million -16.65 Million -79.67 Million 50.54 Million 49.77 Million 183.17 Million
Common Stock 12 Thousand 12 Thousand 8000.00 7000.00 7000.00 6000.00
Retained Earnings -1.48 Billion -1.34 Billion -1.17 Billion -1.06 Billion -873.33 Million -673.74 Million
Accumulated other comprehensive income -161 Thousand -638 Thousand 191 Thousand 518 Thousand -37 Thousand -244 Thousand
Common Stock Equity -136.2 Million -16.65 Million -79.67 Million 50.54 Million 49.77 Million 183.17 Million
Capital Lease Obligation 2.78 Million 8.96 Million 11.28 Million 13.2 Million 14.84 Million -
Total Investments 139.51 Million 142.77 Million 38.15 Million 187.53 Million 135.11 Million 212.17 Million
Total Debt 177.01 Million 172.97 Million 169.29 Million 117.92 Million 109.85 Million 102.66 Million
Net Debt 124.12 Million 37.78 Million -21.16 Million 32.01 Million -19 Million -15.35 Million

Balance Sheet Charts

Created with Highcharts 11.1.0Value in USDYearly Balance Sheet BreakdownCurrent AssetsNon-Current AssetsCurrent LiabilitiesNon-Current LiabilitiesEquity20202021202220230100 M200 M300 M400 M500 M
Created with Highcharts 11.1.0Current RatioWorking CapitalAnnual Working CapitalSource: YRWorking CapitalCurrrent Ratio2020202120222023025050075010001250080 M160 M240 M320 M400 M